111 related articles for article (PubMed ID: 15750167)
21. Mechanisms of tolerance induction and prevention of cardiac allograft vasculopathy in miniature swine: the effect of augmentation of donor antigen load.
Yamada K; Mawulawde K; Menard MT; Shimizu A; Aretz HT; Choo JK; Allison KS; Slisz JK; Sachs DH; Madsen JC
J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):709-19. PubMed ID: 10733759
[TBL] [Abstract][Full Text] [Related]
22. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
[TBL] [Abstract][Full Text] [Related]
23. N-octanoyl Dopamine Attenuates the Development of Transplant Vasculopathy in Rat Aortic Allografts Via Smooth Muscle Cell Protective Mechanisms.
Wedel J; Hottenrott MC; Bulthuis M; Huitema S; Yard BA; Hillebrands JL
Transplantation; 2016 Jan; 100(1):80-90. PubMed ID: 26674731
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of bromodeoxyuridine uptake by smooth muscle cells after arterial injury.
London SM; Mayberg MR
J Vasc Res; 1994; 31(5):247-55. PubMed ID: 7918916
[TBL] [Abstract][Full Text] [Related]
25. [Immunocytochemical investigations of cardiac and vessel allograft arteriosclerosis using smooth muscle cell and macrophage-specific monoclonal antibodies].
Sasaguri S
Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1840-7. PubMed ID: 2608013
[TBL] [Abstract][Full Text] [Related]
26. T-cadherin expression in cardiac allograft vasculopathy: bench to bedside translational investigation.
Collot-Teixeira S; McGregor JL; Morser K; Chalabreysse L; McDermott-Roe C; Cerutti C; Guzman A; Michel JB; Boissonnat P; Sebbag L; Thivolet-Bejui F; Bricca G; Obadia JF; Roussoulières A
J Heart Lung Transplant; 2010 Jul; 29(7):792-9. PubMed ID: 20456977
[TBL] [Abstract][Full Text] [Related]
27. Role of antibody and indirect antigen presentation in transplant-associated coronary artery vasculopathy.
Rose ML
J Heart Lung Transplant; 1996 Apr; 15(4):342-9. PubMed ID: 8732592
[No Abstract] [Full Text] [Related]
28. [Effect of vascular smooth muscle alpha-actin on cardiac allograft vasculopathy and fibrosis].
Zhang M; Yang J; Hu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 34(4):323-6. PubMed ID: 19411749
[TBL] [Abstract][Full Text] [Related]
29. Cardiac CT of the transplanted heart: indications, technique, appearance, and complications.
Bogot NR; Durst R; Shaham D; Admon D
Radiographics; 2007; 27(5):1297-309. PubMed ID: 17848692
[TBL] [Abstract][Full Text] [Related]
30. Impaired vascular smooth muscle nitric oxide-dependent relaxation in human coronary arteries from "transplanted heart vasculopathy".
Salas E; Amado JA; Sánchez de Vega MJ; Poveda JJ; Berrazueta JR
Arch Inst Cardiol Mex; 1997; 67(1):11-6. PubMed ID: 9146817
[TBL] [Abstract][Full Text] [Related]
31. Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients.
Labarrere CA; Pitts D; Nelson DR; Faulk WP
N Engl J Med; 1995 Oct; 333(17):1111-6. PubMed ID: 7565949
[TBL] [Abstract][Full Text] [Related]
32. [Obliterative arteriopathy in renal transplantation: an immunocytochemical analysis].
Tanabe S; Han YS; Nakatani T; Kishimoto T; Suzuki S; Amemiya H; Ueda M
Nihon Hinyokika Gakkai Zasshi; 1993 Oct; 84(10):1828-34. PubMed ID: 8255045
[TBL] [Abstract][Full Text] [Related]
33. [Nuclear cardiology and its application in the study of the patient undergoing cardiac transplant].
Vallejo Venegas E
Arch Inst Cardiol Mex; 2000; 70(6):616-20. PubMed ID: 11255722
[No Abstract] [Full Text] [Related]
34. A key role for matrix metalloproteinases and neutral sphingomyelinase-2 in transplant vasculopathy triggered by anti-HLA antibody.
Galvani S; Trayssac M; Augé N; Thiers JC; Calise D; Krell HW; Sallusto F; Kamar N; Rostaing L; Thomsen M; Nègre-Salvayre A; Salvayre R
Circulation; 2011 Dec; 124(24):2725-34. PubMed ID: 22082680
[TBL] [Abstract][Full Text] [Related]
35. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
[TBL] [Abstract][Full Text] [Related]
36. Allograft-induced proliferation of vascular smooth muscle cells: potential targets for treating transplant vasculopathy.
Autieri MV
Curr Vasc Pharmacol; 2003 Mar; 1(1):1-9. PubMed ID: 15320847
[TBL] [Abstract][Full Text] [Related]
37. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin.
Atkinson C; Horsley J; Rhind-Tutt S; Charman S; Phillpotts CJ; Wallwork J; Goddard MJ
J Heart Lung Transplant; 2004 Apr; 23(4):427-35. PubMed ID: 15063402
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of human smooth muscle cell proliferation and transplant vasculopathy induced by HLA class I antibodies: in vitro and in vivo studies.
Trayssac M; Nègre-Salvayre A; Thomsen M
Hum Immunol; 2012 Dec; 73(12):1253-60. PubMed ID: 22789624
[TBL] [Abstract][Full Text] [Related]
39. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation.
Densem CG; Hutchinson IV; Cooper A; Yonan N; Brooks NH
J Heart Lung Transplant; 2000 Jun; 19(6):551-6. PubMed ID: 10867335
[TBL] [Abstract][Full Text] [Related]
40. Morphometric and immunocytochemical analysis of coronary arterioles in human transplanted hearts.
Armstrong AT; Strauch AR; Kardan A; Starling RC
J Heart Lung Transplant; 1996 Aug; 15(8):818-26. PubMed ID: 8878764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
